Ochsner Health is a system that delivers health to the people of Louisiana, Mississippi and the Gulf South with a mission to Serve, Heal, Lead, Educate and Innovate.
Ochsner Health is a system that delivers health to the people of Louisiana, Mississippi and the Gulf South with a mission to Serve, Heal, Lead, Educate and Innovate.
Thank you for choosing Ochsner Health for your care. We are committed to making an ongoing difference in the health of our communities.
Connect to care at Ochsner. Click on a featured specialty on the list or search for a specialty.
Ochsner is committed to a clinically-integrated research program with the ultimate goal of improving the health and wellness of our patients and communities. And as the largest academic medical center in Louisiana, we are training the next generation of healthcare professionals to be leaders who can meet evolving healthcare challenges.
Dr. Jonathan Hand earned his medical degree from Louisiana State University School of Medicine, New Orleans and completed his internship, residency, and infectious diseases fellowship at the Icahn School of Medicine at Mount Sinai in New York. He is currently an Assistant Professor of Medicine at The University of Queensland School of Medicine Ochsner Clinical School. Dr. Hand specializes in the treatment of infections in immunocompromised patients who anticipate or undergo solid organ or hematopoietic stem cell transplantation as well as patients treated with other immunosuppressive therapies. He is a member of the American Society of Transplantation and serves on the executive committee of the Infectious Diseases community of practice. He is also a member of The Transplantation Society, International Society for Heart and Lung Transplantation, and the Infectious Diseases Society of America. Dr. Hand is the Medical Director of the Antimicrobial Stewardship Program and the Transplant Infectious Diseases Program at Ochsner Medical Center. He also serves as co-chair of the Louisiana Organ Procurement Agency's advisory board providing guidance on infectious diseases-related concerns in organ donors and recipients. His practice and research interests include infectious complications of transplant recipients and antimicrobial stewardship.
Hand JM. The time is now: antimicrobial stewardship in solid organ transplantation. Curr Opin Organ Transplant. 2021 May 25. doi: 10.1097/MOT.0000000000000886. Epub ahead of print. PMID: 34039881.
Bohorquez H, Bugeaud E, Bzowej N, Scheuermann J, Hand J, Bruce D, Carmody I, Cohen A, Joshi S, Seal J, Sonnier D, Therapondos G, Girgrah N, Anders S, Loss GE. Liver Transplantation Using Hepatitis C Virus-Viremic Donors Into Hepatitis C Virus-Aviremic Recipients as Standard of Care. Liver Transpl. 2021 Apr;27(4):548-557. doi: 10.1002/lt.25925. PMID: 33098277.
Durand CM et al. Clarifying the HOPE Act landscape: The challenge of donors with false-positive HIV results. Am J Transplant 2020 Feb; 20(2):617-619.
Hand J, Patel G. Antimicrobial Stewardship in Transplant Patients. Curr Opin Organ Transplant 2019 Aug;24(4):497-503.
Hand J, Huprikar S. #Less is More: Now Trending for Surgical Antibacterial Prophylaxis in Liver Transplantation. Liver Transplantation 2019 Jul;25(7):993-994.
Pellett Madan, R, Hand, J. Human Herpesvirus 6, 7 and 8 in Solid Organ Transplantation‐ Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019 Sep;33(9):e13518
Milani R, Wilt, J, Entwisle J, Hand J, Cazabon P, Bohan J. Reducing Inappropriate Antibiotic Prescribing: Normative Comparison Using Unblinded Provider Reports. BMJ Open Qual 2019;8:e000351
Hand J. Strategies for Antimicrobial Stewardship in Solid Organ Transplant Recipients. Infect Dis Clin North Am. 2018;32(3):535-550.
Nguyen CT, Li J, Anders S, Garcia-Diaz J, Staffeld-Coit C, Hand J. Comparison of outcomes with vancomycin or metronidazole for mild-to-moderate Clostridium difficile associated diarrhea among solid organ transplant recipients: A retrospective cohort study. Transpl Infect Dis. 2018 Jun;20(3):e12867.
Hand J, Sigel K, Huprikar S, Hamula C, Rana M. Tuberculosis (TB) after liver transplantation in a large center in New York City: QuantiFERON((R)) -TB Gold-based pre-transplant screening performance and active TB post transplant. Transpl Infect Dis. 2018 Apr;20(2):e12845.
Nguyen CT, Li J, Occhipinti EA, Hand J. Challenges in procalcitonin implementation in the real-world. Open Forum Infectious Diseases. 2018 Feb;5(2):ofy012.
Hand J, Patel G. Multidrug-resistant organisms in liver transplant - mitigating risk and managing infections. Liver Transplantation. 2016 Aug;22(8):1143-53.
Hand J, Huard G, Rana M, Moon J, Iyer K, Patel G. Cryptosporidiosis Treated with Nitazoxanide in Intestinal Transplantation. Infectious Diseases in Clinical Practice. 2016;24(3):177-179.
Hand J, Huprikar S. Liver transplantation for alveolar echinococcosis: Acceptable when necessary but is it preventable? Liver Transpl. 2015 Aug;21(8):1013-1015.
Altman D, Sebra R, Hand J et al. Transmission of methicillin-resistant Staphylococcus aureus via deceased donor liver transplantation confirmed by whole genome sequencing. Am J Transplant. 2014 Nov; 14(11):2640-2644
Gaisa M, Sigel K, Hand J, Goldstone S. High Rates of Anal Dysplasia in HIV-Infected Men Who Have Sex with Men, Women, and Heterosexual Men. AIDS. 2014 Jan 14;28(2):215-22
We'd love to know more about you so we can deliver the most relevant content.
Which of the following best describes you?
